148 related articles for article (PubMed ID: 7820062)
21. Randomized comparison of pentostatin versus interferon alfa-2a in previously untreated patients with hairy cell leukemia: an intergroup study.
Grever M; Kopecky K; Foucar MK; Head D; Bennett JM; Hutchison RE; Corbett WE; Cassileth PA; Habermann T; Golomb H
J Clin Oncol; 1995 Apr; 13(4):974-82. PubMed ID: 7707126
[TBL] [Abstract][Full Text] [Related]
22. Prolonged, continuous treatment of hairy cell leukemia patients with recombinant interferon-alpha 2a.
Smith JW; Longo DL; Urba WJ; Clark JW; Watson T; Beveridge J; Conlon KC; Sznol M; Creekmore SP; Alvord WG
Blood; 1991 Oct; 78(7):1664-71. PubMed ID: 1912555
[TBL] [Abstract][Full Text] [Related]
23. [The dose of alpha interferon in induction and maintainance therapy of hairy cell leukemia].
Kloke O; May D; Wandl U; Niederle N
Onkologie; 1988; 11 Suppl 2():41-5. PubMed ID: 3065687
[TBL] [Abstract][Full Text] [Related]
24. Hairy cell leukemia: splenectomy after alpha 2b-interferon therapy.
Pangalis GA; Boussiotis VA; Kittas C; Panayiotidis PG; Loukopoulos D; Fessas P; Mitsoulis-Mentzikoff C
Blood; 1991 Sep; 78(5):1385. PubMed ID: 1878598
[No Abstract] [Full Text] [Related]
25. Human recombinant interferon-alpha-2 in the treatment of patients with hairy cell leukemia.
Skotnicki AB; Wolska-Smolen T; Blicharski J; Zduńczyk A; Sasiadek U; Pituch-Noworolska A
Cancer Detect Prev; 1988; 12(1-6):511-22. PubMed ID: 3180143
[TBL] [Abstract][Full Text] [Related]
26. [Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy].
Pralle H; Zwingers T; Boedewadt S; Bross K; Dörken B; Gamm H; Ho AD; Parwaresch RM; Schmitz N; Papendick U
Onkologie; 1987 Feb; 10(1):5-10. PubMed ID: 3295625
[TBL] [Abstract][Full Text] [Related]
27. Hairy cell leukaemia: the role of alpha interferon.
Platanias LC; Ratain MJ
Eur J Cancer; 1991; 27 Suppl 4():S53-7. PubMed ID: 1799481
[TBL] [Abstract][Full Text] [Related]
28. [Efficacy of recombinant interferon alpha-2 in 34 patients with hairy cell leukemia. Effect of splenectomy and dosage reduction results of therapy].
Frey B; Hofmann V; Cavalli F; Fehr J; Kroner T; Nesthus I; Schwarzmeier J
Schweiz Med Wochenschr; 1988 Oct; 118(41):1468-75. PubMed ID: 3238389
[TBL] [Abstract][Full Text] [Related]
29. An unusual indication for splenectomy in hairy cell leukaemia: a report of three cases with persistent splenomegaly after chemoimmunotherapy.
Sarid N; Ahmad HN; Wotherspoon A; Dearden CE; Else M; Catovsky D
Br J Haematol; 2015 Dec; 171(5):784-7. PubMed ID: 26403440
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic advances in the treatment of hairy cell leukemia.
Andrey J; Saven A
Leuk Res; 2001 May; 25(5):361-8. PubMed ID: 11301103
[No Abstract] [Full Text] [Related]
31. An update: 12-year follow-up of patients with hairy cell leukemia following treatment with 2-chlorodeoxyadenosine.
Jehn U; Bartl R; Dietzfelbinger H; Haferlach T; Heinemann V
Leukemia; 2004 Sep; 18(9):1476-81. PubMed ID: 15229616
[TBL] [Abstract][Full Text] [Related]
32. Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.
Ho AD; Thaler J; Mandelli F; Lauria F; Zittoun R; Willemze R; McVie G; Marmont AM; Prümmer O; Stryckmans P
J Clin Oncol; 1989 Oct; 7(10):1533-8. PubMed ID: 2789273
[TBL] [Abstract][Full Text] [Related]
33. Treatment with low dose human recombinant interferon-alpha-2-ARG induces complete remission in patients with hairy cell leukemia.
Gastl G; Denz H; Abbrederis C; Huber H; Troppmair J; Wiegele J; Niederwieser D; Flener R; Huber C
Onkologie; 1985 Jun; 8(3):143-4. PubMed ID: 3895095
[TBL] [Abstract][Full Text] [Related]
34. [Interferon alfa in the treatment of hairy cell leukemia].
Adam Z
Vnitr Lek; 1994 Mar; 40(3):199-202. PubMed ID: 8184577
[TBL] [Abstract][Full Text] [Related]
35. Whole blood assay for NK activity in splenectomized and non-splenectomized hairy cell leukemia patients during IFN-alpha-2b treatment.
Nielsen B; Hokland P; Ellegaard J; Hasselbalch H; Hokland M
Leuk Res; 1989; 13(6):451-6. PubMed ID: 2770329
[TBL] [Abstract][Full Text] [Related]
36. Treatment of hairy-cell leukaemia with alpha-interferon (alpha-IFN).
Lauria F; Foà R; Raspadori D; Zinzani PL; Buzzi M; Fierro MT; Bonferroni M; Fanin R; Gallizia C; Michieli MG
Eur J Cancer Clin Oncol; 1988 Feb; 24(2):195-200. PubMed ID: 3356206
[TBL] [Abstract][Full Text] [Related]
37. [Interferon-alpha in the treatment of hairy cell leukemia. New perspectives].
Flandrin G
Presse Med; 1993 Jan 2-16; 22(1):9-12. PubMed ID: 8097039
[No Abstract] [Full Text] [Related]
38. [Improvement with interferon-alpha therapy and splenectomy in hairy cell leukemia of European-American type].
Yasuyama M; Kawauchi K; Sugiyama H; Mori H; Enomoto Y; Watanabe Y; Machii T; Kitani T
Rinsho Ketsueki; 1992 Mar; 33(3):365-70. PubMed ID: 1578641
[TBL] [Abstract][Full Text] [Related]
39. Low-dose interferon alfa-2b in the treatment of hairy cell leukemia.
Moormeier JA; Ratain MJ; Westbrook CA; Vardiman JW; Daly KM; Golomb HM
J Natl Cancer Inst; 1989 Aug; 81(15):1172-4. PubMed ID: 2746669
[TBL] [Abstract][Full Text] [Related]
40. Treatment of hairy cell leukemia with increasing doses of recombinant alpha A interferon.
Holmes R; Schwarz MA; Whiteside MG; Firkin FC
Aust N Z J Med; 1988 Jun; 18(4):557-62. PubMed ID: 3196242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
